Rasagiline improves quality of life in patients with early Parkinson's disease-Reference-Cited by-同舟云学术

Rasagiline improves quality of life in patients with early Parkinson's disease

Published:2006-05 Issue:5 Volume:21 Page:616-623
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Biglan Kevin M.,Schwid Steven,Eberly Shirley,Blindauer Karen,Fahn Stanley,Goren Tamar,Kieburtz Karl,Oakes David,Plumb Sandra,Siderowf Andrew,Stern Matthew,Shoulson Ira,

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference20 articles.

1. Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease

2. Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations

3. Quality of life outcomes following surgical treatment of Parkinson's disease

4. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population

5. Quality of life measurements in patients with Parkinson's disease: A community-based study

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

2. Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson’s disease: A systematic review;npj Parkinson's Disease;2022-06-13

3. Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2021-01

4. Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer’s Disease;Current Pharmaceutical Design;2020-10-26

5. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease;European Journal of Medicinal Chemistry;2019-05